Published in Cases J on November 07, 2008
Chagas' disease: pregnancy and congenital transmission. Biomed Res Int (2014) 0.98
Congenital Trypanosoma cruzi infection. Efficacy of its monitoring in an urban reference health center in a non-endemic area of Argentina. Am J Trop Med Hyg (2010) 0.94
Acute chagas disease: new global challenges for an old neglected disease. PLoS Negl Trop Dis (2014) 0.93
Identification of a Western blot pattern for the specific diagnosis of Trypanosoma cruzi infection in human sera. Am J Trop Med Hyg (2012) 0.91
Achievements and challenges upon the implementation of a program for national control of congenital Chagas in Bolivia: results 2004-2009. PLoS Negl Trop Dis (2013) 0.84
Sensitivity and specificity of an operon immunochromatographic test in serum and whole-blood samples for the diagnosis of Trypanosoma cruzi infection in Spain, an area of nonendemicity. Clin Vaccine Immunol (2012) 0.83
Impact of chagas disease in bolivian immigrants living in europe and the risk of stigmatization. J Parasitol Res (2014) 0.83
Trypanosoma cruzi infection: a review with emphasis on cutaneous manifestations. Int J Dermatol (2012) 0.81
Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries. World J Cardiol (2012) 0.79
Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci U S A (1993) 3.40
DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Mol Biochem Parasitol (1996) 2.90
Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction. J Clin Microbiol (1989) 2.58
A nested polymerase chain reaction (Ln-PCR) for diagnosing and monitoring Leishmania infantum infection in patients co-infected with human immunodeficiency virus. Trans R Soc Trop Med Hyg (2002) 1.97
Congenital transmission of Trypanosoma cruzi in Europe (Spain): a case report. Am J Trop Med Hyg (2006) 1.47
Congenital Trypanosoma cruzi infection in a non-endemic area. Trans R Soc Trop Med Hyg (2007) 1.41
Congenital transmission of Trypanosoma cruzi is associated with maternal enhanced parasitemia and decreased production of interferon- gamma in response to parasite antigens. J Infect Dis (2004) 1.27
The mini-exon gene: a genetic marker for zymodeme III of Trypanosoma cruzi. Mol Biochem Parasitol (1998) 1.08
Are maternal re-infections with Trypanosoma cruzi associated with higher morbidity and mortality of congenital Chagas disease? Trop Med Int Health (2006) 0.97
[Estimation of the parasitemia in Trypanosoma cruzi human infection: high parasitemias are associated with severe and fatal congenital Chagas disease]. Rev Soc Bras Med Trop (2005) 0.92
[Serum levels for IgM and IgA antibodies to anti-trypanosoma cruzi in samples of blood from newborns from mothers with positive serology for Chagas disease]. Rev Soc Bras Med Trop (2005) 0.82
The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev (2008) 5.32
Canine leishmaniasis. Adv Parasitol (2004) 2.44
Spread of vector-borne diseases and neglect of Leishmaniasis, Europe. Emerg Infect Dis (2008) 2.24
Leishmania/HIV co-infections in the second decade. Indian J Med Res (2006) 1.73
Leishmaniases in the Mediterranean in the era of molecular epidemiology. Trends Parasitol (2008) 1.50
Seroepidemiologic study of Leishmania infantum infection in Castilla-Leon, Spain. Am J Trop Med Hyg (2004) 1.48
Kala-azar outbreak in Libo Kemkem, Ethiopia: epidemiologic and parasitologic assessment. Am J Trop Med Hyg (2007) 1.44
Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis. J Clin Microbiol (2006) 1.26
Risk factors for visceral leishmaniasis in a new epidemic site in Amhara Region, Ethiopia. Am J Trop Med Hyg (2009) 1.25
Differentiation and gene flow among European populations of Leishmania infantum MON-1. PLoS Negl Trop Dis (2008) 1.23
Transfusional chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. Clin Infect Dis (2008) 1.15
Comparison of molecular markers for strain typing of Leishmania infantum. Infect Genet Evol (2006) 1.09
[Comparison of conventional and non-conventional serological tests for the diagnosis of imported Chagas disease in Spain]. Enferm Infecc Microbiol Clin (2009) 1.07
Drug regimens for visceral leishmaniasis in Mediterranean countries. Trop Med Int Health (2008) 1.07
Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. J Antimicrob Chemother (2004) 1.06
An approach for interlaboratory comparison of conventional and real-time PCR assays for diagnosis of human leishmaniasis. Exp Parasitol (2013) 1.05
Differential diagnosis of Taenia saginata and Taenia saginata asiatica taeniasis through PCR. Diagn Microbiol Infect Dis (2004) 1.03
A canine leishmaniasis pilot survey in an emerging focus of visceral leishmaniasis: Posadas (Misiones, Argentina). BMC Infect Dis (2010) 1.03
Relapses versus reinfections in patients coinfected with Leishmania infantum and human immunodeficiency virus type 1. J Infect Dis (2002) 1.01
Thelaziosis in humans, a zoonotic infection, Spain, 2011. Emerg Infect Dis (2012) 1.00
Evaluation of two rK39 dipstick tests, direct agglutination test, and indirect fluorescent antibody test for diagnosis of visceral leishmaniasis in a new epidemic site in highland Ethiopia. Am J Trop Med Hyg (2011) 1.00
Schistosoma mansoni: a diagnostic approach to detect acute schistosomiasis infection in a murine model by PCR. Exp Parasitol (2006) 0.99
Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis. Vet Dermatol (2009) 0.98
Fluorogenic assay for molecular typing of the Leishmania donovani complex: taxonomic and clinical applications. J Infect Dis (2005) 0.97
Factors associated with Leishmania asymptomatic infection: results from a cross-sectional survey in highland northern Ethiopia. PLoS Negl Trop Dis (2012) 0.94
Assessing the validity of an ELISA test for the serological diagnosis of human fascioliasis in different epidemiological situations. Trop Med Int Health (2012) 0.93
Detection and discrimination of Loa loa, Mansonella perstans and Wuchereria bancrofti by PCR-RFLP and nested-PCR of ribosomal DNA ITS1 region. Exp Parasitol (2010) 0.93
PCR tools for the differential diagnosis of Taenia saginata and Taenia solium taeniasis/cysticercosis from different geographical locations. Diagn Microbiol Infect Dis (2002) 0.93
Real-time PCR assay for detection and quantification of Leishmania (Viannia) organisms in skin and mucosal lesions: exploratory study of parasite load and clinical parameters. J Clin Microbiol (2013) 0.92
Low prevalence of Leishmania infection in post-epidemic areas of Libo Kemkem, Ethiopia. Am J Trop Med Hyg (2012) 0.91
Alternative PCR protocol using a single primer set for assessing DNA quality in several tissues from a large variety of mammalian species living in areas endemic for leishmaniasis. Mem Inst Oswaldo Cruz (2010) 0.90
Trypanosoma cruzi infection in Elche (Spain): comparison of the seroprevalence in immigrants from Paraguay and Bolivia. Pathog Glob Health (2012) 0.90
Usefulness of the rK39-immunochromatographic test, direct agglutination test, and leishmanin skin test for detecting asymptomatic Leishmania infection in children in a new visceral leishmaniasis focus in Amhara State, Ethiopia. Am J Trop Med Hyg (2012) 0.90
Characterization of the biology and infectivity of Leishmania infantum viscerotropic and dermotropic strains isolated from HIV+ and HIV- patients in the murine model of visceral leishmaniasis. Parasit Vectors (2013) 0.89
Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis. Vaccine (2008) 0.89
Molecular cloning and characterisation of Ts8B1, Ts8B2 and Ts8B3, three new members of the Taenia solium metacestode 8 kDa diagnostic antigen family. Mol Biochem Parasitol (2006) 0.89
Endemic transmission of visceral leishmaniasis in Bhutan. Am J Trop Med Hyg (2012) 0.88
Virulence and disease in leishmaniasis: what is relevant for the patient? Trends Parasitol (2004) 0.86
Evaluation of recombinant HP6-Tsag, an 18 kDa Taenia saginata oncospheral adhesion protein, for the diagnosis of cysticercosis. Parasitol Res (2007) 0.86
Cloning and characterization of Taenia saginata paramyosin cDNA. Parasitol Res (2003) 0.86
Evaluation of Trichinella spiralis larva group 1 antigens for serodiagnosis of human trichinellosis. J Clin Microbiol (2004) 0.86
Taenia solium: characterization of a small heat shock protein (Tsol-sHSP35.6) and its possible relevance to the diagnosis and pathogenesis of neurocysticercosis. Exp Parasitol (2005) 0.86
Allergic rhinitis and its impact on work productivity in primary care practice and a comparison with other common diseases: the Cross-sectional study to evAluate work Productivity in allergic Rhinitis compared with other common dIseases (CAPRI) study. Am J Rhinol Allergy (2012) 0.86
Multilocus microsatellite typing revealed high genetic variability of Leishmania donovani strains isolated during and after a Kala-azar epidemic in Libo Kemkem district, northwest Ethiopia. Microbes Infect (2011) 0.85
Serological screening of Chagas disease in an immigrant population in Asturias, Spain proceeding from Chagas-endemic areas. Scand J Infect Dis (2009) 0.84
What is responsible for a large and unusual outbreak of leishmaniasis in Madrid? Trends Parasitol (2013) 0.84
The MF6p/FhHDM-1 major antigen secreted by the trematode parasite Fasciola hepatica is a heme-binding protein. J Biol Chem (2013) 0.84
Trichinella spiralis secretes a homologue of prosaposin. Mol Biochem Parasitol (2004) 0.84
Sensitivity and specificity of an operon immunochromatographic test in serum and whole-blood samples for the diagnosis of Trypanosoma cruzi infection in Spain, an area of nonendemicity. Clin Vaccine Immunol (2012) 0.83
Sequence analysis of the 3'-untranslated region of HSP70 (type I) genes in the genus Leishmania: its usefulness as a molecular marker for species identification. Parasit Vectors (2012) 0.83
Effects of HIV aspartyl-proteinase inhibitors on Leishmania sp. Exp Parasitol (2010) 0.83
[Antiparasite therapy]. Enferm Infecc Microbiol Clin (2003) 0.82
Genomic and functional characterisation of a secreted antigen of Taenia saginata oncospheres. Mol Biochem Parasitol (2002) 0.82
The Leishmania HSP20 is antigenic during natural infections, but, as DNA vaccine, it does not protect BALB/c mice against experimental L. amazonensis infection. J Biomed Biotechnol (2008) 0.82
Drug susceptibility of Leishmania infantum (syn. Leishmania chagasi) isolates from Brazilian HIV-positive and HIV-negative patients. J Antimicrob Chemother (2011) 0.82
Effects of the disruption of the HSP70-II gene on the growth, morphology, and virulence of Leishmania infantum promastigotes. Int Microbiol (2008) 0.81
[Autochthonous amebic liver abscess in Spain: an emerging disease? Case report and description of a PCR-based diagnostic test]. Enferm Infecc Microbiol Clin (2009) 0.81
Ddi1-like protein from Leishmania major is an active aspartyl proteinase. Cell Stress Chaperones (2012) 0.81
TSOL18/HP6-Tsol, an immunogenic Taenia solium oncospheral adhesion protein and potential protective antigen. Parasitol Res (2008) 0.81
The Taenia saginata homologue of the major surface antigen of Echinococcus spp. is immunogenic and 97% identical to its Taenia solium homologue. Parasitol Res (2007) 0.80
Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica. Eur J Med Chem (2011) 0.80
Peptide epitopes of the Taenia solium antigen Ts8B2 are immunodominant in human and porcine cysticercosis. Mol Biochem Parasitol (2009) 0.80
Diagnostic epitope variability within Taenia solium 8 kDa antigen family: implications for cysticercosis immunodetection. Exp Parasitol (2011) 0.80
Long-term outcome in Caucasian patients with chronic hepatitis B virus infection after HBsAg seroclearance. Liver Int (2014) 0.80
Monoclonal antibodies raised in Btk(xid) mice reveal new antigenic relationships and molecular interactions among gp53 and other Trichinella glycoproteins. Mol Biochem Parasitol (2002) 0.80
Oncospheral peptide-based ELISAs as potential seroepidemiological tools for Taenia solium cysticercosis/neurocysticercosis in Venezuela. Trans R Soc Trop Med Hyg (2005) 0.80
Development and evaluation of a new lateral flow immunoassay for serodiagnosis of human fasciolosis. PLoS Negl Trop Dis (2011) 0.80
A recombinant enolase from Anisakis simplex is differentially recognized in natural human and mouse experimental infections. Med Microbiol Immunol (2005) 0.79
MISS-Prot: web server for self/non-self discrimination of protein residue networks in parasites; theory and experiments in Fasciola peptides and Anisakis allergens. Mol Biosyst (2011) 0.79
LEISHMANIA INFANTUM INFECTION IN BENNETT'S WALLABIES (MACROPUS RUFOGRISEUS RUFOGRISEUS) IN A SPANISH WILDLIFE PARK. J Zoo Wildl Med (2016) 0.78
Mixed infection, Trichinella spiralis and Trichinella britovi, in a wild boar hunted in the Province of Cáceres (Spain). Exp Parasitol (2008) 0.78
Epidemiology and genetic risk of type 1 diabetes among children in Aragon community, Spain. Diabetes Res Clin Pract (2007) 0.78
Genetic variability of the 18 kDa/HP6 protective antigen in Taenia saginata and Taenia asiatica: implications for vaccine development. Mol Biochem Parasitol (2011) 0.78
Cutaneous and medullar gnathostomiasis in travelers to Mexico and Thailand. J Travel Med (2003) 0.78
First diagnosis of an imported human myiasis caused by Hypoderma sinense (Diptera: Oestridae), detected in a European traveler returning from India. J Travel Med (2010) 0.78
Gender differences in major depressive disorder: somatic symptoms and quality of life. Rev Psiquiatr Salud Ment (2009) 0.78
Characterization of the Taenia spp HDP2 sequence and development of a novel PCR-based assay for discrimination of Taenia saginata from Taenia asiatica. Parasit Vectors (2010) 0.77
Long-term survival in a smoking caucasian male patient treated with gefitinib for spinal cord compression secondary to lung cancer. Onkologie (2011) 0.77
[Diagnosis of human taeniasis by multiplex-PCR]. Med Clin (Barc) (2003) 0.77
[Application of the PCR-RFLP technique for the species-specific identification of nematodes involved in human anisakiasis]. Med Clin (Barc) (2004) 0.76
Postnatal and adult immunoglobulin repertoires of innate-like CD19(+)CD45R(lo) B Cells. J Innate Immun (2014) 0.76